共 50 条
- [31] Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression” Clinical Drug Investigation, 2023, 43 : 79 - 80
- [32] Mental health service use among adolescents and young adults with major depressive disorder and suicidality CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2007, 52 (04): : 228 - 232
- [38] The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2017, 20 (10): : 782 - 787
- [39] Correction to: Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression” Clinical Drug Investigation, 2023, 43 : 81 - 81